COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,189 Articles (22,713 medRxiv, 8,476 bioRxiv)

Most recent first Previous |  Page 1166: Articles 11651-11660  | Next

Effect of the third dose of BNT162b2 vaccine in quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare workers
Romero-Ibarguengoitia, M. E., Rivera-Salinas, D., Hernandez-Ruiz, Y. G., Armendariz-Vazquez, A. G., Gonzalez-Cantu, A., Barco-Flores, I. A., Gonzalez-Facio, R., Montelongo-Cruz, L. P., Del Rio-Parra, G. F., Garza-Herrera, M. R., Leal Melendez, J. A., Sanz-Sanchez, M. A.
10.1101/2021.10.20.21265269 — Posted: 2021-10-21
Food Security Impacts of the COVID-19 Pandemic: Following a Cohort of Vermonters During the First Year
McCarthy, A. C., Belarmino, E. H., Bertmann, F. M., Niles, M. T.
10.1101/2021.10.20.21265283 — Posted: 2021-10-21
Multireader Evaluation of Radiologist Performance for COVID-19 Detection on Emergency Department Chest Radiographs
Gichoya, J. W., Sinha, P., Davis, M., Dunkle, J. W., Hamlin, S. A., Herr, K. D., Hoff, C. N., Letter, H. P., McAdams, C. R., Puthoff, G. D., Smith, K. L., Steenburg, S. D., Banerjee, I., Trivedi, H.
10.1101/2021.10.20.21265278 — Posted: 2021-10-21
Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
Zeng, C., Evans, J. P., Reisinger, S., Woyach, J., Liscynesky, C., Boghdadly, Z. E., Rubinstein, M. P., Chakravarthy, K., Saif, L., Oltz, E. M., Gumina, R. J., Shields, P. G., Li, Z., Liu, S.-L.
10.1101/2021.10.20.21265273 — Posted: 2021-10-21
Wastewater-Based Epidemiological Modeling for Continuous Surveillance of COVID-19 Outbreak
Fazli, M., Sklar, S., Porter, M. D., French, B. A., Shakeri, H.
10.1101/2021.10.19.21265221 — Posted: 2021-10-20
Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities
Bierle, D. M., Ganesh, R., Tulledge-Scheitel, S. M., Hanson, S. N., Arndt, L. L., Wilker, C. G., Razonable, R. R.
10.1101/2021.10.19.21265222 — Posted: 2021-10-20
Modeling remdesivir antiviral efficacy in COVID-19 hospitalized patients of the randomized, controlled, open-label DisCoVeRy trial
Lingas, G., Neant, N., Gaymard, A., Belhadi, D., Peytavin, G., Hites, M., Staub, T., Greil, R., Paiva, J.-A., Poissy, J., Peiffer-Smadja, N., Costagliola, D., Yazdanpanah, Y., Wallet, F., Gagneux-Brunon, A., Mentre, F., Ader, F., Burdet, C., Guedj, J., Bouscambert-Duchamp, M., DisCoVeRy study group
10.1101/2021.10.19.21265209 — Posted: 2021-10-20
Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts
Siddle, K. J., Krasilnikova, L. A., Moreno, G. K., Schaffner, S. F., Vostok, J., Fitzgerald, N. A., Lemieux, J. E., Barkas, N., Loreth, C., Specht, I., Tomkins-Tinch, C. H., Silbert, J., Schaeffer, B., Taylor, B. P., Loftness, B., Johnson, H., Schubert, P. L., Shephard, H. M., Doucette, M., Fink, T., Lang, A. S., Baez, S., Beauchamp, J., Hennigan, S., Buzby, E., Ash, S., Brown, J., Clancy, S., Cofsky, S., Gagne, L., Hall, J., Harrington, R., Gionet, G. L., DeRuff, K. C., Vodzak, M. E., Adams, G. C., Dobbins, S. T., Slack, S. D., Reilly, S. K., Anderson, L. M., Cipicchio, M. C., DeFelice, M. T., Grimsby, J. L., Anderson, S. E., Blumenstiel, B. S., Meldrim, J. C., Rooke, H. M., Vicente, G., Smith, N. L., Messer, K. S., Reagan, F. L., Mandese, Z. M., Lee, M. D., Ray, M. C., Fisher, M. E., Ulcena, M. A., Nolet, C. M., English, S. E., Larkin, K. L., Vernest, K., Chaluvadi, S., Arvidson, D., Melchiono, M., Covell, T., Harik, V., Brock-Fisher, T., Dunn, M., Kearns, A., Hanage, W. P., Bernard, C., Philippakis, A., Lennon, N. J., Gabriel, S. B., Gallagher, G. R., Smole, S., Madoff, L. C., Brown, C. M., Park, D. J., MacInnis, B. L., Sabeti, P. C.
10.1101/2021.10.20.21265137 — Posted: 2021-10-20 Discussion: Onsite
Airborne transmission of SARS-CoV-2 over distances greater than two metres: a rapid systematic review
Palmer, J. C., Duval, D., Tudge, I., Sarfo-Annin, J. K., Pearce-Smith, N., O'Connell, E., Bennett, A., Clark, R.
10.1101/2021.10.19.21265208 — Posted: 2021-10-20
Mutations on non-structural proteins of SARS-CoV-2 are possibly responsible for adverse clinical outcomes in a real-life practice
Ichikawa, T., Torii, S., Suzuki, H., Takada, A., Suzuki, S., Nakajima, M., Tampo, A., kakinoki, y.
10.1101/2021.10.19.21265062 — Posted: 2021-10-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).